Publications by authors named "Qunmei Yao"

What Is Already Known About This Topic?: () is a species of toxic mushroom known to induce symptoms of photosensitive dermatitis.

What Is Added By This Report?: In the months of May and June 2023, a total of four patients in Chuxiong Yi Autonomous Prefecture, Yunnan Province, were affected by poisoning, occurring over two distinct incidents. The condition of two patients deteriorated after they were re-exposed to sunlight on the seventh day following the initial poisoning.

View Article and Find Full Text PDF
Article Synopsis
  • Lepiota brunneoincarnata is a toxic mushroom that can cause severe liver and kidney damage, with two cases reported in a mother and son from Yunnan, China.
  • Both patients showed gastrointestinal symptoms shortly after eating the mushrooms and were diagnosed with acute liver and kidney injuries after seeking medical help.
  • Treatments included activated charcoal and other medications, leading to one patient's complete recovery, while the other faced ongoing kidney issues, eventually requiring multiple treatments and facing chronic kidney insufficiency months later.
View Article and Find Full Text PDF

Background: Mushroom poisoning is a major public health issue in China. The integration of medical resources from different institutes of different levels is crucial in reducing the harm of mushroom poisoning. However, few studies have provided comprehensive implementation procedures and postimplementation effectiveness evaluations.

View Article and Find Full Text PDF
Article Synopsis
  • * A new method for detecting protein-bound α-amanitin was developed, which involves trypsin hydrolysis and conventional liquid chromatography-mass spectrometry (LC‒MS) analysis.
  • * This method extended the detection window for protein-bound α-amanitin to 10 days and achieved a detection rate of 53.33%, significantly better than the 0-4 hour window for free α-amanitin.
View Article and Find Full Text PDF

Approximately 70-90% of mushroom poisoning deaths are caused by α-amanitin-induced liver injury resulting from RNA polymerase II (RNAP II) inhibition. Liver regeneration ability may contribute greatly to individual survival after α-amanitin poisoning. However, it is unclear what cellular pathways are activated to stimulate regeneration.

View Article and Find Full Text PDF

Mushroom toxicity is the main branch of foodborne poisoning, and liver damage caused by amatoxin poisoning accounts for more than 90 % of deaths due to mushroom poisoning. Alpha-amatoxin (α-AMA) has been considered the primary toxin from amatoxin-containing mushrooms, which is responsible for hepatotoxicity and death. However, the mechanism underlying liver failure due to α-AMA remains unclear.

View Article and Find Full Text PDF

In order to explore the role of apoptosis in alpha-amatoxin (α-AMA) induced liver injury and probable upstream activation signals, we established animal and cellular models, respectively, for this pathophysiological condition. To this end, we evaluated the survival rate and serum biochemical parameters in BALB/c mice exposed to α-AMA at different time periods, along with the levels of oxidative and antioxidant enzymes in the liver tissue of these mice and proteins involved in apoptosis-related pathways. Our results reveal that α-AMA-induced apoptosis occurs primarily through the mitochondrial apoptotic pathway and is associated with oxidative damage.

View Article and Find Full Text PDF

Amatoxins and phallotoxins are toxic cyclopeptides found in the genus Amanita and are among the predominant causes of fatal food poisoning in China. In the treatment of Amanita mushroom poisoning, an early and definite diagnosis is necessary for a successful outcome, which has prompted the development of protocols for the fast and confirmatory determination of amatoxins and phallotoxins in human biological fluids. For this purpose, a simple, rapid and sensitive multiresidue UPLC-MS/MS method for the simultaneous determination of α-amanitin, β-amanitin, γ-amanitin, phalloidin (PHD) and phallacidin (PCD) in human plasma, serum and urine was developed and validated.

View Article and Find Full Text PDF